Logo
Login
$CTXR
$0.50 +$0.05 (11.62%) Close

Ownership

13F as of Q2 2026 · 27.5M shares outstanding

Who owns CTXR?

By type of holder
Institutions 4.9% Insiders 1.8% Everyone else 93.3%
Concentration Top 10 holders own 5.4%
Mazur Leonard L 1.5% · Geode Capital Management, LLC 0.8%
Institutional ownership
4.9%
+1.3 pts vs last qtr
Institutional holders
41
+3 vs last qtr
Net shares bought
+350.8K
by institutions in Q2 2026
New / sold out
12 / 9
positions opened vs closed

How is ownership changing?

Institutions, last 8 quarters

Biggest buyers in Q2 2026
  • Citadel Advisors LLC NEW +124.9K
  • Miller Financial Services LLC +116.0K

Sign up to see all 5.

Biggest sellers in Q2 2026
  • HRT Financial LP SOLD OUT −60.3K
  • Susquehanna International Group, LLP SOLD OUT −36.8K

Sign up to see all 5.

Who is planning to sell?

No insider has filed a notice of proposed sale (Form 144) for Citius Pharmaceuticals Inc in the last 12 months.

Is your stake being diluted?

Diluted share count, FY2021–FY2025
+134.3%
+23.73% a year
Each share's claim on the business
−57.3%
shrank without buying or selling a share
Spent on buybacks vs paid in stock
— vs $34.7M
over 5 fiscal years
Diluted shares, split-adjusted
4.6M7.9M11.2M2021: 4.7M shares'212022: 6.4M shares'222023: 6.1M shares'232024: 6.7M shares'242025: 11.1M shares'25
Buybacks Stock-based comp
$0$5.9M$11.8M2021 buybacks: $02021 stock comp: $1.5M'212022 buybacks: $02022 stock comp: $3.9M'222023 buybacks: $02023 stock comp: $6.6M'232024 buybacks: $02024 stock comp: $11.8M'242025 buybacks: $02025 stock comp: $10.8M'25

How patient are the owners?

Institutional shares by how long they've been held
5+ years0% 3–5 years0% 1–3 years59% Under 1 year41%
Quarterly turnover
34.8%
of institutional shares changed hands
Top 10 managers, median time held
1.5 years

Super Investors

Investment managers reporting CTXR on Form 13F
GC
Geode Capital Management, LLC
Shares
215.5K
% of company
0.79%
Change vs last qtr
−30.6K (−12.4%)
Held since
2024
VC
Vanguard Capital Management LLC
Shares
197.4K
% of company
0.72%
Change vs last qtr
+29.6K (+17.7%)
Held since
2024

28 more super investors behind a free account

See every manager holding Citius Pharmaceuticals Inc, how their position has changed, and how long they've held it.

Sign up free

Institutional Funds

Mutual funds and ETFs reporting CTXR on Form N-PORT; together they hold 1.4% of the company
VE
Vanguard Extended Market Index Fund
Vanguard Index Funds
Position value
$101K
% of company
0.61%
% of the fund
0.00%
As of
June 30, 2026
FE
Fidelity Extended Market Index Fund
Fidelity Concord Street Trust
Position value
$95.8K
% of company
0.60%
% of the fund
0.00%
As of
August 31, 2026

3 more funds behind a free account

See every fund holding Citius Pharmaceuticals Inc and how much of the fund the position is.

Sign up free

Insiders and 5%+ holders

From Forms 3/4/5 and Schedules 13D/G
ML
Mazur Leonard L
Insider
Shares
410.2K
% of company
1.49%
Change vs last qtr
—
Held since
—
HM
Holubiak Myron Z
Insider
Shares
79.7K
% of company
0.29%
Change vs last qtr
—
Held since
—

3 more holders behind a free account

See every insider and 5%+ holder of Citius Pharmaceuticals Inc.

Sign up free

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support
View Pricing Plans